Early breast cancer: Evaluation of the prognostic role of the site of the primary tumor

被引:79
作者
Zucali, R
Mariani, L
Marubini, E
Kenda, R
Lozza, L
Rilke, F
Veronesi, U
机构
[1] Ist Nazl Tumori, Dept Radiotherapy, I-20133 Milan, Italy
[2] Ist Nazl Tumori, Dept Biometry, I-20133 Milan, Italy
[3] Ist Nazl Tumori, Dept Pathol, I-20133 Milan, Italy
[4] Univ Milan, Inst Biometry & Stat Med, Milan, Italy
[5] European Inst Oncol, Milan, Italy
关键词
D O I
10.1200/JCO.1998.16.4.1363
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The prognostic role of the site of the primary breast cancer has not been clarified. This study aimed to gather more information about this issue from a large series of patients with long-term follow-up data. Patients and Methods: Data from 2,396 patients treated for early breast cancer with a conservative approach were reviewed (1973 to 1989). In 1,619 patients, the tumor had a lateral site, while in 777 cases, it was situated in the internal/central quadrants. The characteristics of the two groups were well balanced, apart from axillary nodal metastases, which were more frequent for lateral tumors (38.1% v 26.3%). Results: Analysis of distant metastases indicated that the regression coefficient associated with tumor site was significant and the hazards ratio estimate was 1.291, which indicates the risk of distant metastases was increased by approximately 30% for internal/central tumors. The analysis of overall survival yielded a significant coefficient and a hazards ratio of 1.192, which indicates an approximately 20% increase of mortality for internal/central tumors. Conclusion: Early breast cancers situated in central/internal quadrants have a worse prognosis compared with those in lateral quadrants, in terms of distant metastases and survival. Irradiation of the internal mammary chain for internal/medial rumors could be suggested, but, to date, the therapeutic strategy is still controversial. (C) 1998 by American Society of Clinical Oncology.
引用
收藏
页码:1363 / 1366
页数:4
相关论文
共 23 条
[1]   ADEQUATE LOCOREGIONAL TREATMENT FOR EARLY BREAST-CANCER MAY PREVENT SECONDARY DISSEMINATION [J].
ARRIAGADA, R ;
RUTQVIST, LE ;
MATTSSON, A ;
KRAMAR, A ;
ROTSTEIN, S .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2869-2878
[2]  
BONADONNA G, 1977, CANCER-AM CANCER SOC, V39, P2904, DOI 10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO
[3]  
2-8
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]   CAUSE-SPECIFIC MORTALITY IN LONG-TERM SURVIVORS OF BREAST-CANCER WHO PARTICIPATED IN TRIALS OF RADIOTHERAPY [J].
CUZICK, J ;
STEWART, H ;
RUTQVIST, L ;
HOUGHTON, J ;
EDWARDS, R ;
REDMOND, C ;
PETO, R ;
BAUM, M ;
FISHER, B ;
HOST, H ;
LYTHGOE, J ;
RIBEIRO, G ;
SCHEURLEN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :447-453
[6]   10-YEAR RESULTS OF A RANDOMIZED CLINICAL-TRIAL COMPARING RADICAL MASTECTOMY AND TOTAL MASTECTOMY WITH OR WITHOUT RADIATION [J].
FISHER, B ;
REDMOND, C ;
FISHER, ER ;
BAUER, M ;
WOLMARK, N ;
WICKERHAM, DL ;
DEUTSCH, M ;
MONTAGUE, E ;
MARGOLESE, R ;
FOSTER, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (11) :674-681
[7]   POSTOPERATIVE RADIOTHERAPY IN BREAST-CANCER - LONG-TERM RESULTS FROM THE OSLO STUDY [J].
HOST, H ;
BRENNHOVD, IO ;
LOEB, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (05) :727-732
[8]  
LE MG, 1990, CANCER, V66, P2313, DOI 10.1002/1097-0142(19901201)66:11<2313::AID-CNCR2820661110>3.0.CO
[9]  
2-M
[10]   Review on internal mammary node irradiation [J].
Morgan, DAL .
BREAST, 1996, 5 (02) :57-60